Literature DB >> 10544307

Hazard function estimators: a simulation study.

K R Hess1, D M Serachitopol, B W Brown.   

Abstract

Kernel-based methods for the smooth, non-parametric estimation of the hazard function have received considerable attention in the statistical literature. Although the mathematical properties of the kernel-based hazard estimators have been carefully studied, their statistical properties have not. We reviewed various kernel-based methods for hazard function estimation from right-censored data and compared the statistical properties of these estimators through computer simulations. Our simulations covered seven distributions, three levels of random censoring, four types of bandwidth functions, two sample sizes and three types of boundary correction. We conducted a total of 504 simulation experiments with 500 independent samples each. Our results confirmed the advantages of two recent innovations in kernel estimation - boundary correction and locally optimal bandwidths. The median relative improvement (decrease) in mean square error over fixed-bandwidth estimators without boundary correction was 3 per cent for fixed-bandwidth estimators with left boundary correction, 52 per cent locally optimal bandwidths without boundary correction, and 66 per cent for locally optimal bandwidths with left boundary correction. The locally optimal bandwidth estimators with left boundary correction also outperformed three previously published and publicly available algorithms, with median relative improvements in mean square error of 31 per cent, 77 per cent and 80 per cent. Copyright 1999 John Wiley & Sons, Ltd.

Mesh:

Year:  1999        PMID: 10544307     DOI: 10.1002/(sici)1097-0258(19991130)18:22<3075::aid-sim244>3.0.co;2-6

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  25 in total

1.  Incorporating follow-up time in M-estimation for survival data.

Authors:  Glenn Heller
Journal:  Lifetime Data Anal       Date:  2004-03       Impact factor: 1.588

2.  Mortality in the randomized, controlled lung intergroup trial of isotretinoin.

Authors:  J Jack Lee; Lei Feng; Daniel S Reshef; Anita L Sabichi; Brendell Williams; Waree Rinsurongkawong; Ignacio I Wistuba; Reuben Lotan; Scott M Lippman
Journal:  Cancer Prev Res (Phila)       Date:  2010-05-25

3.  Application of a hazard-based visual predictive check to evaluate parametric hazard models.

Authors:  Yeamin Huh; Matthew M Hutmacher
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-11-13       Impact factor: 2.745

4.  Poorly Differentiated Clusters Predict Colon Cancer Recurrence: An In-Depth Comparative Analysis of Invasive-Front Prognostic Markers.

Authors:  Tsuyoshi Konishi; Yoshifumi Shimada; Lik Hang Lee; Marcela S Cavalcanti; Meier Hsu; Jesse Joshua Smith; Garrett M Nash; Larissa K Temple; José G Guillem; Philip B Paty; Julio Garcia-Aguilar; Efsevia Vakiani; Mithat Gonen; Jinru Shia; Martin R Weiser
Journal:  Am J Surg Pathol       Date:  2018-06       Impact factor: 6.394

5.  Confidence intervals for the first crossing point of two hazard functions.

Authors:  Ming-Yen Cheng; Peihua Qiu; Xianming Tan; Dongsheng Tu
Journal:  Lifetime Data Anal       Date:  2009-11-01       Impact factor: 1.588

6.  Myocardial Recovery in Patients Receiving Contemporary Left Ventricular Assist Devices: Results From the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS).

Authors:  Veli K Topkara; A Reshad Garan; Barry Fine; Amandine F Godier-Furnémont; Alexander Breskin; Barbara Cagliostro; Melana Yuzefpolskaya; Koji Takeda; Hiroo Takayama; Donna M Mancini; Yoshifumi Naka; Paolo C Colombo
Journal:  Circ Heart Fail       Date:  2016-07       Impact factor: 8.790

7.  Time-Varying Effects of Breast Cancer Adjuvant Systemic Therapy.

Authors:  Ismail Jatoi; Hanna Bandos; Jong-Hyeon Jeong; William F Anderson; Edward H Romond; Eleftherios P Mamounas; Norman Wolmark
Journal:  J Natl Cancer Inst       Date:  2015-10-30       Impact factor: 13.506

8.  Risk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapy.

Authors:  Huifeng Yun; Fenglong Xie; Elizabeth Delzell; Lang Chen; Emily B Levitan; James D Lewis; Kenneth G Saag; Timothy Beukelman; Kevin Winthrop; John W Baddley; Jeffrey R Curtis
Journal:  Ann Rheum Dis       Date:  2014-03-07       Impact factor: 19.103

9.  Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer.

Authors:  Soley Bayraktar; Leonel F Hernadez-Aya; Xiudong Lei; Funda Meric-Bernstam; Jennifer K Litton; Limin Hsu; Gabriel N Hortobagyi; Ana M Gonzalez-Angulo
Journal:  Cancer       Date:  2011-07-28       Impact factor: 6.860

10.  Latent subgroup analysis of a randomized clinical trial through a semiparametric accelerated failure time mixture model.

Authors:  L Altstein; G Li
Journal:  Biometrics       Date:  2013-02-05       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.